undefined
EUTM file information

018517170

METEOR

July 18, 2021

Trademark Summary

The trademark application METEOR was filed by GAMMADELTA THERAPEUTICS LTD, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 24, 2021, and it was registered by office on December 1, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on July 27, 2022. A transfer of the trademark registration was recorded on November 15, 2022.

Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Unprocessed artificial resins, unprocessed plastics
    2. Fire extinguishing and fire prevention compositions
    3. Tempering and soldering preparations
    4. Substances for tanning animal skins and hides
    5. Adhesives for use in industry
    6. Putties and other paste fillers
    7. Biological preparations for use in industry and science
    8. Biological substances, biological materials and biological preparations, and natural elements
    9. Biological compositions and materials for use in science
    10. Antibodies and multi-specific antibodies for scientific purposes, other than for medical or veterinary use
    11. Antibody reagents for scientific purposes
    12. Tagged antibodies and multi-specific antibodies for scientific use
    13. Tagged antibodies and multi-specific antibodies for laboratory use
    14. Proteins for binding antibodies and multi-specific antibodies [other than for medical use]
    15. Proteins for detecting antibodies and multi-specific antibodies [other than for medical use]
    16. Biochemical precursors for scientific purposes
    17. Biochemical preparations for scientific purposes
    18. Biochemical reagents used for non-medical purposes
    19. Active chemical ingredients for use in the manufacture of anti-cancer, auto-immune and anti-infective drugs
    20. Active chemical ingredients for use in the manufacture of drugs and cell therapy products
    21. Adhesives for use on transdermal drug delivery components
    22. Chemical substances for use in the production of drugs
    23. Chemical substances, chemical materials and chemical preparations, and natural elements in relation to antibodies and multi-specific antibodies
    24. Biological substances, biological materials and biological preparations, and natural elements in relation to antibodies and multi-specific antibodies
    25. Chemical substances, chemical materials and chemical preparations, and natural elements in relation to immunohistochemistry (IHC) and flow cytometry
    26. Biological substances, biological materials and biological preparations, and natural elements in relation to immunohistochemistry (IHC) and flow cytometry
    27. Chemical substances, chemical materials and chemical preparations, and natural elements in relation to gamma delta t cells
    28. Biological substances, biological materials and biological preparations, and natural elements in relation to gamma delta t cells
    29. Chemical compositions and materials for use in science in relation to antibodies and multi-specific antibodies
    30. Chemical compositions and materials for use in science in relation to gamma delta t cells
    31. Chemical compositions and materials for use in science in relation to immunohistochemistry (IHC) and flow cytometry
    32. Biological compositions and materials for use in science in relation to antibodies and multi-specific antibodies
    33. Biological compositions and materials for use in science in relation to gamma delta t cells
    34. Biological compositions and materials for use in science in relation to immunohistochemistry (IHC) and flow cytometry
    35. Biochemical and biological precursors for scientific purposes in relation to antibodies and multi-specific antibodies
    36. Biochemical and biological precursors for scientific purposes in relation to gamma delta t cells
    37. Biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry
    38. Biochemical and biological preparations for scientific purposes in relation to antibodies and multi-specific antibodies
    39. Biochemical and biological preparations for scientific purposes in relation to gamma delta t cells
    40. Biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry
    41. Biochemical and biological reagents used for non-medical purposes in relation to antibodies and multi-specific antibodies
    42. Biochemical and biological reagents used for non-medical purposes in relation to gamma delta t cells
    43. Biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry
    44. None of the aforesaid goods in relation to agriculture, horticulture or forestry.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals, medical and veterinary preparations
    2. Sanitary preparations for medical purposes
    3. Dietetic food and substances adapted for medical or veterinary use, food for babies
    4. Dietary supplements for human beings and animals
    5. Plasters, materials for dressings
    6. Material for stopping teeth, dental wax
    7. Disinfectants
    8. Antibodies and multi-specific antibodies
    9. Biotechnological preparations for medical use
    10. Capsules for pharmaceutical purposes
    11. Drug delivery agents
    12. Drugs for medical purposes
    13. Injectable pharmaceuticals
    14. Medical preparations and articles
    15. Medicines for human purposes
    16. Pharmaceutical compositions
    17. Pharmaceutical drugs
    18. Pharmaceutical preparations
    19. Pharmaceutical preparations and substances
    20. Pharmaceutical preparations for activating cellular function
    21. Pharmaceutical preparations for human use
    22. Pharmaceutical preparations for immunity adjustment
    23. Pharmaceutical preparations for medical purposes
    24. Pharmaceutical preparations for regulating the immune system
    25. Pharmaceutical preparations for the prevention of autoimmune diseases
    26. Pharmaceutical preparations for the prevention of autoimmune disorders
    27. Pharmaceutical preparations for the treatment of autoimmune diseases
    28. Pharmaceutical preparations for the treatment of autoimmune disorders
    29. Pharmaceutical preparations for the treatment of cancer
    30. Pharmaceutical preparations for the treatment of viral diseases
    31. Pharmaceutical preparations for the treatment of anti-infective diseases
    32. Pharmaceutical preparations for use in oncology
    33. Pharmaceutical products for the treatment of cancer
    34. Pharmaceutical products for the treatment of viral diseases
    35. Pharmaceutical products for the treatment of anti-infective diseases
    36. Pharmaceuticals
    37. Pharmaceuticals and natural remedies
    38. Biotechnological preparations for medical use in relation to antibodies and multi-specific antibodies
    39. Biotechnological preparations for medical use in relation to gamma delta t cells
    40. Biotechnological preparations for medical use in relation to immunohistochemistry (IHC) and flow cytometry
    41. Chemical preparations for pharmaceutical purposes in relation to antibodies and multi-specific antibodies
    42. Chemical preparations for pharmaceutical purposes in relation to gamma delta t cells
    43. Chemical preparations for pharmaceutical purposes in relation to immunohistochemistry (IHC) and flow cytometry
    44. Chemicals for pharmaceutical use in relation to antibodies and multi-specific antibodies
    45. Chemicals for pharmaceutical use in relation to gamma delta t cells
    46. Chemicals for pharmaceutical use in relation to immunohistochemistry (IHC) and flow cytometry
    47. Drug delivery agents in relation to antibodies and multi-specific antibodies
    48. Drug delivery agents in relation to gamma delta t cells
    49. Drug delivery agents in relation to immunohistochemistry (IHC) and flow cytometry
    50. Drugs for medical purposes in relation to antibodies and multi-specific antibodies
    51. Drugs for medical purposes in relation to gamma delta t cells
    52. Drugs for medical purposes in relation to immunohistochemistry (IHC) and flow cytometry
    53. Pharmaceutical preparations and substances in relation to antibodies and multi-specific antibodies
    54. Pharmaceutical preparations and substances in relation to gamma delta t cells
    55. Pharmaceutical preparations and substances in relation to immunohistochemistry (IHC) and flow cytometry
    56. Pharmaceutical products in relation to antibodies and multi-specific antibodies
    57. Pharmaceutical products in relation to gamma delta t cells
    58. Pharmaceutical products in relation to immunohistochemistry (IHC) and flow cytometry
    59. Pharmaceuticals and natural remedies in relation to antibodies and multi-specific antibodies
    60. Pharmaceuticals and natural remedies in relation to gamma delta t cells
    61. Pharmaceuticals and natural remedies in relation to immunohistochemistry (IHC) and flow cytometry
    62. None of the aforesaid goods in relation to agriculture, horticulture or forestry.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services and research and design relating thereto
    2. Industrial analysis, industrial research and industrial design services
    3. Quality control and authentication services
    4. Design and development of computer hardware and software
    5. Biological research, clinical research and medical research
    6. Biomedical research services
    7. Clinical research
    8. Clinical trials
    9. Conducting clinical trials
    10. Conducting clinical trials for pharmaceutical products
    11. Conducting early evaluations in the field of new pharmaceuticals
    12. Consultancy in the field of pharmaceutical research
    13. Consultancy relating to pharmaceutical research and development
    14. Development of pharmaceutical preparations and medicines
    15. Drug discovery services
    16. Information technology services for the pharmaceutical and healthcare industries
    17. Inspection of pharmaceuticals
    18. Laboratory research services relating to pharmaceuticals
    19. Medical and pharmacological research services
    20. Pharmaceutical drug development services
    21. Pharmaceutical product evaluation
    22. Pharmaceutical products development
    23. Pharmaceutical research and development
    24. Pharmaceutical research and development services
    25. Pharmaceutical research services
    26. Providing information about the results of clinical trials for pharmaceutical products
    27. Research and development in the pharmaceutical and biotechnology fields
    28. Research and development of vaccines and medicines
    29. Research and development services in the field of antibodies and multi-specific antibodies
    30. Research and development services in the field of antibody technology
    31. Research relating to medicines
    32. Science and technology services
    33. Scientific research and development
    34. Design and development of medical diagnostic apparatus
    35. Design and development of diagnostic apparatus
    36. Design of diagnostic apparatus and equipment
    37. Design of diagnostic apparatus
    38. Development of diagnostic apparatus
    39. Research and development in the field of diagnostic preparations
    40. Biological research, clinical research and medical research in relation to antibodies and multi-specific antibodies
    41. Biological research, clinical research and medical research in relation to gamma delta t cells
    42. Biological research, clinical research and medical research in relation to immunohistochemistry (IHC) and flow cytometry
    43. Consultancy relating to pharmaceutical research and development in relation to antibodies and multi-specific antibodies
    44. Consultancy relating to pharmaceutical research and development in relation to gamma delta t cells
    45. Consultancy relating to pharmaceutical research and development in relation to immunohistochemistry (IHC) and flow cytometry
    46. Laboratory research services relating to pharmaceuticals in relation to antibodies and multi-specific antibodies
    47. Laboratory research services relating to pharmaceuticals in relation to gamma delta t cells
    48. Laboratory research services relating to pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry
    49. Medical and pharmacological research services in relation to antibodies and multi-specific antibodies
    50. Medical and pharmacological research services in relation to gamma delta t cells
    51. Medical and pharmacological research services in relation to immunohistochemistry (IHC) and flow cytometry
    52. Pharmaceutical research and development services in relation to antibodies and multi-specific antibodies
    53. Pharmaceutical research and development services in relation to gamma delta t cells
    54. Pharmaceutical research and development services in relation to immunohistochemistry (IHC) and flow cytometry
    55. Science and technology services in relation to antibodies and multi-specific antibodies
    56. Science and technology services in relation to gamma delta t cells
    57. Science and technology services in relation to immunohistochemistry (IHC) and flow cytometry
    58. Scientific research and development in relation to antibodies and multi-specific antibodies
    59. Scientific research and development in relation to gamma delta t cells
    60. Scientific research and development in relation to immunohistochemistry (IHC) and flow cytometry
    61. Information, advisory and consultancy services relating the aforesaid services, and none of the aforesaid services in relation to agriculture, horticulture or forestry.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services
    2. Veterinary services
    3. Hygienic and beauty care for human beings or animals
    4. Advisory services relating to pharmaceuticals
    5. Consultancy and information services provided via the internet relating to pharmaceutical products
    6. Consultancy and information services relating to biopharmaceutical products
    7. Consultancy and information services relating to pharmaceutical products
    8. Drug screening for medical purposes
    9. Drug testing for substance abuse
    10. Human healthcare services
    11. Pharmaceutical advice
    12. Pharmaceutical advisory services
    13. Pharmaceutical consultation
    14. Pharmaceutical services
    15. Provision of pharmaceutical information
    16. Conducting sleep studies for medical diagnostic or treatment purposes
    17. Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
    18. Medical diagnostic services
    19. Medical testing for diagnostic or treatment purposes
    20. Surgical diagnostic services
    21. Pharmaceutical advice in relation to antibodies and multi-specific antibodies
    22. Pharmaceutical advice in relation to gamma delta t cells
    23. Pharmaceutical advice in relation to immunohistochemistry (IHC) and flow cytometry
    24. Pharmaceutical advisory services in relation to antibodies and multi-specific antibodies
    25. Pharmaceutical advisory services in relation to gamma delta t cells
    26. Pharmaceutical advisory services in relation immunohistochemistry (IHC) and flow cytometry
    27. Pharmaceutical consultation in relation to antibodies and multi-specific antibodies
    28. Pharmaceutical consultation in relation to gamma delta t cells
    29. Pharmaceutical consultation in relation to immunohistochemistry (IHC) and flow cytometry
    30. Pharmaceutical services in relation to antibodies and multi-specific antibodies
    31. Pharmaceutical services in relation to gamma delta t cells
    32. Pharmaceutical services in relation to immunohistochemistry (IHC) and flow cytometry
    33. Provision of pharmaceutical information in relation to antibodies and multi-specific antibodies
    34. Provision of pharmaceutical information in relation to gamma delta t cells
    35. Provision of pharmaceutical information in relation to immunohistochemistry (IHC) and flow cytometry
    36. Information, advisory and consultancy services relating the aforesaid services, and none of the aforesaid services in relation to agriculture, horticulture or forestry.